Kunihiko Ito Selected Research

thyrotropin-binding inhibitory immunoglobulin

1/2011	Persistent high TRAb values during pregnancy predict increased risk of neonatal hyperthyroidism following radioiodine therapy for refractory hyperthyroidism.
9/2007	Recent outcome of Graves' disease patients with papillary thyroid cancer.
6/2004	Surgical treatment of Graves' disease in children.
1/2004	Stimulation of thyroid-stimulating hormone (TSH) receptor antibody production following painless thyroiditis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kunihiko Ito Research Topics

Disease

17	Tuberculosis (Tuberculoses) 10/2019 - 04/2004
10	Graves Disease (Basedow Disease) 02/2014 - 06/2004
5	Infections 01/2012 - 06/2004
4	Liver Diseases (Liver Disease) 10/2016 - 01/2007
4	Latent Tuberculosis 10/2016 - 11/2009
4	Neoplasms (Cancer) 01/2013 - 01/2004
4	Pulmonary Tuberculosis 01/2007 - 10/2004
3	Follicular Adenocarcinoma 01/2013 - 07/2011
3	Hyperthyroidism 01/2012 - 06/2004
3	Thyroid Diseases (Thyroid Disease) 01/2011 - 01/2004
2	Adenoma (Adenomas) 01/2013 - 12/2011
2	Thyroid Nodule (Nodule, Thyroid) 01/2013 - 12/2011
2	Neoplasm Metastasis (Metastasis) 08/2012 - 07/2011
2	Thyrotoxicosis 07/2012 - 12/2011
2	Goiter 12/2011 - 06/2004
2	Thyroiditis 01/2011 - 01/2004
1	Retinitis Pigmentosa (Pigmentary Retinopathy) 01/2021
1	Agranulocytosis (Granulocytopenia) 01/2012
1	Pancytopenia 01/2012
1	Hypothyroidism 12/2011
1	Papillary Thyroid Cancer 07/2011
1	B-Cell Lymphoma (Lymphoma, B Cell) 04/2011
1	Inflammation (Inflammations) 01/2011
1	Primary Hyperparathyroidism 01/2010
1	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 08/2009
1	Vasculitis (Vasculitides) 08/2009
1	Hypocalcemia 12/2008
1	Substance-Related Disorders (Drug Abuse) 09/2008
1	Mental Disorders (Mental Disorder) 09/2008
1	Peritonitis 08/2007
1	Thyroid Neoplasms (Thyroid Cancer) 06/2007
1	Paraganglioma (Paragangliomas) 06/2007
1	Meningitis 12/2006
1	Empyema 10/2004
1	Hemoptysis 07/2004
1	Nausea 10/2002

Drug/Important Bio-Agent (IBA)

11	Pharmaceutical PreparationsIBA 10/2016 - 06/2004
8	Isoniazid (Ftivazide)FDA LinkGeneric 10/2016 - 01/2005
5	Rifampin (Rifampicin)FDA LinkGeneric 10/2016 - 01/2005
5	Antithyroid Agents (Antithyroid Drugs)IBA 02/2014 - 06/2004
4	thyrotropin-binding inhibitory immunoglobulinIBA 01/2011 - 01/2004
3	RacivirIBA 01/2013 - 07/2011
3	AntibodiesIBA 01/2011 - 06/2007
2	AcidsIBA 10/2019 - 09/2006
2	Methimazole (Thiamazole)FDA LinkGeneric 07/2012 - 08/2009
2	Propylthiouracil FDA Link 07/2012 - 08/2009
2	Parathyroid Hormone (Parathormone)IBA 01/2010 - 12/2008
2	AntigensIBA 10/2004 - 01/2004
1	Interferon-gamma (Interferon, gamma)IBA 10/2019
1	TransferasesIBA 05/2016
1	Guanosine Triphosphate (GTP)IBA 05/2016
1	Alkaline PhosphataseIBA 05/2016
1	Antitubercular AgentsIBA 10/2014
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2012
1	SteroidsIBA 01/2012
1	Ethanol (Ethyl Alcohol)IBA 12/2011
1	Troleandomycin (TAO)FDA Link 01/2011
1	Thyroxine (Levothyroxine)FDA LinkGeneric 01/2011
1	Thyrotropin Receptors (Thyrotropin Receptor)IBA 01/2011
1	GlucocorticoidsIBA 01/2011
1	Long-Acting Thyroid Stimulator (LATS)IBA 01/2011
1	GoldIBA 11/2009
1	Peroxidase (Myeloperoxidase)IBA 08/2009
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 08/2009
1	Vitamin D FDA LinkGeneric 12/2008
1	CalciumIBA 12/2008
1	Carcinoembryonic AntigenIBA 06/2007
1	Chromogranin AIBA 06/2007
1	Thyroglobulin FDA Link 06/2007
1	ParaffinIBA 06/2007
1	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 06/2007
1	Phosphopyruvate Hydratase (Enolase)IBA 06/2007
1	Thioacetazone (Thiacetazone)IBA 01/2007
1	Fluorescent Dyes (Fluorescent Probes)IBA 05/2006
1	Coloring Agents (Dyes)IBA 05/2006
1	C-Reactive ProteinIBA 04/2004
1	Hematoxylin (Haematoxylon)IBA 01/2004
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 01/2004
1	Capsules (Microcapsules)IBA 01/2004
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2004
1	Fluvoxamine (Luvox)FDA LinkGeneric 10/2002
1	Serotonin (5 Hydroxytryptamine)IBA 10/2002
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 10/2002

Therapy/Procedure

10	Therapeutics 09/2016 - 06/2004
7	Thyroidectomy 01/2013 - 06/2004
5	Drug Therapy (Chemotherapy) 04/2011 - 04/2004
2	Duration of Therapy 10/2014 - 02/2007
1	Prostheses and Implants (Prosthesis) 01/2021
1	Bathroom Equipment 06/2012
1	Length of Stay 06/2012
1	Operative Surgical Procedures 01/2012
1	Conservative Treatment 07/2011
1	Radiotherapy 04/2011
1	Combined Modality Therapy 04/2011
1	Minimally Invasive Surgical Procedures 01/2010
1	Oral Medicine 08/2007